← Open Payments lookup

TOYIN MARCUS: Open Payments

NPI 1942831425 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,150 in 42 payments from 10 companies in 2025. Trend: 2023 $1,552 · 2024 $2,370 · 2025 $2,150

Food & beverage: $2,150
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc6$447
E.R. Squibb & Sons, L.L.C.6$349
Teva Pharmaceuticals USA, Inc.10$327
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$198
Otsuka America Pharmaceutical, Inc.7$175
Alkermes, Inc.4$161
ABBVIE INC.1$125
Axsome Therapeutics, Inc.1$125
Neurocrine BioSciences, Inc.1$122
Boehringer Ingelheim Pharmaceuticals, Inc.1$122

Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, AUSTEDO XR, UZEDY, ABILIFY MAINTENA, VRAYLAR, Auvelity.

Industry payments across AZ — which companies pay providers there.